162 related articles for article (PubMed ID: 2509390)
41. Transmission electron microscopic observations on ultrastructural alterations in Schistosoma mansoni adult worms recovered from C57BL/6 mice treated with radiation-attenuated vaccine and/or praziquantel in addition to passive immunization with normal and vaccinated rabbit sera against infection.
El-Shabasy EA; Reda ES; Abdeen SH; Said AE; Ouhtit A
Parasitol Res; 2015 Apr; 114(4):1563-80. PubMed ID: 25786393
[TBL] [Abstract][Full Text] [Related]
42. Schistosoma mansoni: chemotherapy of infections of different ages.
Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
[TBL] [Abstract][Full Text] [Related]
43. Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.
Coeli R; Baba EH; Araujo N; Coelho PM; Oliveira G
PLoS Negl Trop Dis; 2013; 7(12):e2596. PubMed ID: 24367712
[TBL] [Abstract][Full Text] [Related]
44. Comparative efficacy and bioavailability of different praziquantel brands.
Botros S; El-Lakkany N; Seif el-Din SH; Sabra AN; Ibrahim M
Exp Parasitol; 2011 Feb; 127(2):515-21. PubMed ID: 21044626
[TBL] [Abstract][Full Text] [Related]
45. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
[TBL] [Abstract][Full Text] [Related]
46. Drug-metabolizing enzymes and praziquantel bioavailability in mice harboring Schistosoma mansoni isolates of different drug susceptibilities.
Botros SS; El-Din SH; El-Lakkany NM; Sabra AN; Ebeid FA
J Parasitol; 2006 Dec; 92(6):1344-9. PubMed ID: 17304818
[TBL] [Abstract][Full Text] [Related]
47. Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo.
Modha J; Lambertucci JR; Doenhoff MJ; McLaren DJ
Parasite Immunol; 1990 May; 12(3):321-34. PubMed ID: 2117266
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of avocado/soybean unsaponifiable alone or concurrently with praziquantel in murine schistosomiasis.
Soliman MF
Acta Trop; 2012 Jun; 122(3):261-6. PubMed ID: 22342904
[TBL] [Abstract][Full Text] [Related]
49. Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel.
Fallon PG; Doenhoff MJ
Parasite Immunol; 1995 May; 17(5):261-8. PubMed ID: 7675513
[TBL] [Abstract][Full Text] [Related]
50. TPT sulfonate, a single, oral dose schistosomicidal prodrug: In vivo efficacy, disposition and metabolic profiling.
Wolfe AR; Neitz RJ; Burlingame M; Suzuki BM; Lim KC; Scheideler M; Nelson DL; Benet LZ; Caffrey CR
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):571-586. PubMed ID: 30503203
[TBL] [Abstract][Full Text] [Related]
51. In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections.
Lamberton PH; Hogan SC; Kabatereine NB; Fenwick A; Webster JP
Am J Trop Med Hyg; 2010 Dec; 83(6):1340-7. PubMed ID: 21118946
[TBL] [Abstract][Full Text] [Related]
52. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.
Ismail M; Botros S; Metwally A; William S; Farghally A; Tao LF; Day TA; Bennett JL
Am J Trop Med Hyg; 1999 Jun; 60(6):932-5. PubMed ID: 10403323
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni.
Mattos AC; Pereira GC; Jannotti-Passos LK; Kusel JR; Coelho PM
Acta Trop; 2007 May; 102(2):84-91. PubMed ID: 17498638
[TBL] [Abstract][Full Text] [Related]
54. A single dose of the antineoplastics hydroxyurea or cisplatin has praziquantel-like effects on Schistosoma mansoni worms and host mouse liver.
Eldeeb E; Fahmy S; Elbakry K; Hyder A
Biomed Pharmacother; 2018 Mar; 99():570-575. PubMed ID: 29902867
[TBL] [Abstract][Full Text] [Related]
55. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
Bonesso-Sabadini PI; de Souza Dias LC
Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
[TBL] [Abstract][Full Text] [Related]
56. Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice.
Doenhoff MJ; Sabah AA; Fletcher C; Webbe G; Bain J
Trans R Soc Trop Med Hyg; 1987; 81(6):947-51. PubMed ID: 3140436
[TBL] [Abstract][Full Text] [Related]
57. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
Fallon PG; Fookes RE; Wharton GA
Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
[TBL] [Abstract][Full Text] [Related]
58. The effect of praziquantel treatment on the liver functions, worm burden, and granuloma size using two drug regimen in murine Schistosoma mansoni infection.
el-Fakahany AF; Abdalla KF; el-Hady HM; Abd el-Aziz SM; Afifi LM
J Egypt Soc Parasitol; 1993 Dec; 23(3):877-86. PubMed ID: 8308363
[TBL] [Abstract][Full Text] [Related]
59. Validation of sensitivity to praziquantel using Schistosoma mansoni worm muscle tension and Ca2+-uptake as possible in vitro correlates to in vivo ED50 determination.
William S; Botros S
Int J Parasitol; 2004 Jul; 34(8):971-7. PubMed ID: 15217736
[TBL] [Abstract][Full Text] [Related]
60. Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation.
de Jesus MB; Pinto Lde M; Fraceto LF; Magalhães LA; Zanotti-Magalhães EM; de Paula E
J Drug Target; 2010 Jan; 18(1):21-6. PubMed ID: 19624246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
